Literature DB >> 32778020

Current Trends on Repurposing and Pharmacological Enhancement of Andrographolide.

Xuan Ren1, Wenzhou Xu2, Jiao Sun3, Biao Dong4, Hussein Awala5, Lin Wang1.   

Abstract

Andrographolide, the main bioactive component separated from Andrographis paniculata in 1951, has been scrutinized with a modern drug discovery approach for anti-inflammatory properties since 1984. Identification of new uses of existing drugs can be facilitated by searching for evidence linking them to known or yet undiscovered drug targets and human disease states to develop new therapeutic indications.Furthermore, a wide spectrum of biological properties of andrographolide such as anticancer, antibacterial, antiviral, hepatoprotective, antioxidant, anti-malarial, anti-atherosclerosis are also reported. However, poor water solubility and instability limit its clinical application. It becomes crucial to enhance its pharmacological function and find a new treatment option for more diseases. Therefore, this article reviews the major recent developments in andrographolide, including repurposing applications in different diseases and underlying mechanisms, particularly focusing on pharmacological enhancement of andrographolide such as derivatives, chemical modifications with potent biological activity and drug delivery. The repurposing and pharmacological enhancement of andrographolide would not only have exciting therapeutic potential to different diseases to facilitate drug marketing, but also decrease the economic burden on healthcare worldwide. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Andrographolide; anti-cancer; anti-microorganism; antioxidation; bioavailability; drug delivery; drug repurposing; hepatoprotective

Year:  2021        PMID: 32778020     DOI: 10.2174/0929867327666200810135604

Source DB:  PubMed          Journal:  Curr Med Chem        ISSN: 0929-8673            Impact factor:   4.530


  1 in total

1.  Synthesis and Characterization of Andrographolide Derivatives as Regulators of βAPP Processing in Human Cells.

Authors:  Arpita Dey; Ran Chen; Feng Li; Subhamita Maitra; Jean-Francois Hernandez; Guo-Chun Zhou; Bruno Vincent
Journal:  Molecules       Date:  2021-12-17       Impact factor: 4.411

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.